Cystic Fibrosis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...
NHS hope as new miracle drug greatly reduces some cystic fibrosis symptoms
The genetic condition cystic fibrosis had no treatments on the NHS before 2019 and a Daily Express campaign - now a miracle ...
Science Daily3d
Lung Disease News
cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in ... Feb. 6, 2025 ...
Medscape7h
Racial Disparities Widen in Modern Cystic Fibrosis Care
Among the candidates listed for lung transplant, those with an indication of CF decreased from 13.3% in the pre–highly ...
Thorax7d
AI-powered evaluation of lung function for diagnosis of interstitial lung disease
Background The diagnosis of interstitial lung disease (ILD) can pose a challenge as the pulmonary function test (PFT) is only ...
McGill University Health Centre4d
Major funding for research project on cystic fibrosis
A new research project focusing on rare genetic mutations that are linked to cystic fibrosis just received $600,000 in ...
PMLive8d
Vertex’s triple combination cystic fibrosis therapy Alyftrek approved by MHRA
Vertex Pharmaceuticals’ triple combination cystic fibrosis (CF) treatment has been approved by the Medicines and Healthcare ...
Rowan Today2d
PRSSA to host 32nd annual Organ Donor Day event
The Rowan University chapter of the Public Relations Student Society of America (PRSSA) will hold its 32 nd annual Organ ...
Pharmabiz13d
Patients and experts urge Court to ensure access to cystic fibrosis in India
The patients of cystic fibrosis (CF), their families, and public health experts are pinning their hopes on the expected outcome from the Karnataka High Court regarding availability of affordable ...
EurekAlert!9d
Research shows positive impact of CFTR modulators on pregnancy outcomes in people with cystic fibrosis
A recent retrospective study published in CHEST(Opens in a new window) evaluated the effects of cystic fibrosis transmembrane conductance regulator (CFTR) modulator use on pregnancy outcomes in ...